BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35948494)

  • 1. Bacteria-mediated metformin-loaded peptide hydrogel reprograms the tumor immune microenvironment in glioblastoma.
    Zhu L; Liu J; Qiu M; Chen J; Liang Q; Peng G; Zou Z
    Biomaterials; 2022 Sep; 288():121711. PubMed ID: 35948494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel.
    Jin H; Wan C; Zou Z; Zhao G; Zhang L; Geng Y; Chen T; Huang A; Jiang F; Feng JP; Lovell JF; Chen J; Wu G; Yang K
    ACS Nano; 2018 Apr; 12(4):3295-3310. PubMed ID: 29558107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.
    Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L
    J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels.
    Wang C; Tong X; Yang F
    Mol Pharm; 2014 Jul; 11(7):2115-25. PubMed ID: 24712441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.
    Dai X; Meng J; Deng S; Zhang L; Wan C; Lu L; Huang J; Hu Y; Zhang Z; Li Y; Lovell JF; Wu G; Yang K; Jin H
    Theranostics; 2020; 10(7):3049-3063. PubMed ID: 32194854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
    Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
    J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinacrine Mediated Sensitization of Glioblastoma (GBM) Cells to TRAIL through MMP-Sensitive PEG Hydrogel Carriers.
    Erkoc P; Cingöz A; Onder TB; Kizilel S
    Macromol Biosci; 2017 Feb; 17(2):. PubMed ID: 27762493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells.
    Rao G; Latha K; Ott M; Sabbagh A; Marisetty A; Ling X; Zamler D; Doucette TA; Yang Y; Kong LY; Wei J; Fuller GN; Benavides F; Sonabend AM; Long J; Li S; Curran M; Heimberger AB
    Clin Cancer Res; 2020 Sep; 26(17):4699-4712. PubMed ID: 32554515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogel matrix presence and composition influence drug responses of encapsulated glioblastoma spheroids.
    Hill L; Bruns J; Zustiak SP
    Acta Biomater; 2021 Sep; 132():437-447. PubMed ID: 34010694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melittin-Containing Hybrid Peptide Hydrogels for Enhanced Photothermal Therapy of Glioblastoma.
    Jin H; Zhao G; Hu J; Ren Q; Yang K; Wan C; Huang A; Li P; Feng JP; Chen J; Zou Z
    ACS Appl Mater Interfaces; 2017 Aug; 9(31):25755-25766. PubMed ID: 28714303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
    Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
    Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Cancer Cell Metabolism with Metformin, Dichloroacetate and Memantine in Glioblastoma (GBM).
    Albayrak G; Konac E; Dere UA; Emmez H
    Turk Neurosurg; 2021; 31(2):233-237. PubMed ID: 33372258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration.
    Uneda A; Kurozumi K; Fujimura A; Fujii K; Ishida J; Shimazu Y; Otani Y; Tomita Y; Hattori Y; Matsumoto Y; Tsuboi N; Makino K; Hirano S; Kamiya A; Date I
    Acta Neuropathol Commun; 2021 Feb; 9(1):29. PubMed ID: 33618763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures.
    Gonçalves DPN; Rodriguez RD; Kurth T; Bray LJ; Binner M; Jungnickel C; Gür FN; Poser SW; Schmidt TL; Zahn DRT; Androutsellis-Theotokis A; Schlierf M; Werner C
    Acta Biomater; 2017 Aug; 58():12-25. PubMed ID: 28576716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype.
    Liu YC; Lee IC; Chen PY
    J Neurooncol; 2018 May; 137(3):511-522. PubMed ID: 29357090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perivascular signals alter global gene expression profile of glioblastoma and response to temozolomide in a gelatin hydrogel.
    Ngo MT; Harley BAC
    Biomaterials; 2019 Apr; 198():122-134. PubMed ID: 29941152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
    Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M
    Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment.
    Hong S; You JY; Paek K; Park J; Kang SJ; Han EH; Choi N; Chung S; Rhee WJ; Kim JA
    Theranostics; 2021; 11(19):9687-9704. PubMed ID: 34646393
    [No Abstract]   [Full Text] [Related]  

  • 19. Metformin treatment reduces temozolomide resistance of glioblastoma cells.
    Yang SH; Li S; Lu G; Xue H; Kim DH; Zhu JJ; Liu Y
    Oncotarget; 2016 Nov; 7(48):78787-78803. PubMed ID: 27791206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin.
    Kim EH; Lee JH; Oh Y; Koh I; Shim JK; Park J; Choi J; Yun M; Jeon JY; Huh YM; Chang JH; Kim SH; Kim KS; Cheong JH; Kim P; Kang SG
    Neuro Oncol; 2017 Feb; 19(2):197-207. PubMed ID: 27571886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.